rs2278163

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005220.3(DLX3):​c.-64C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.256 in 1,568,052 control chromosomes in the GnomAD database, including 57,752 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 6491 hom., cov: 34)
Exomes 𝑓: 0.25 ( 51261 hom. )

Consequence

DLX3
NM_005220.3 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.67

Publications

26 publications found
Variant links:
Genes affected
DLX3 (HGNC:2916): (distal-less homeobox 3) Many vertebrate homeo box-containing genes have been identified on the basis of their sequence similarity with Drosophila developmental genes. Members of the Dlx gene family contain a homeobox that is related to that of Distal-less (Dll), a gene expressed in the head and limbs of the developing fruit fly. The Distal-less (Dlx) family of genes comprises at least 6 different members, DLX1-DLX6. Trichodentoosseous syndrome (TDO), an autosomal dominant condition, has been correlated with DLX3 gene mutation. This gene is located in a tail-to-tail configuration with another member of the gene family on the long arm of chromosome 17. Mutations in this gene have been associated with the autosomal dominant conditions trichodentoosseous syndrome and amelogenesis imperfecta with taurodontism. [provided by RefSeq, Jul 2008]
DLX3 Gene-Disease associations (from GenCC):
  • tricho-dento-osseous syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 17-49995062-G-A is Benign according to our data. Variant chr17-49995062-G-A is described in ClinVar as Benign. ClinVar VariationId is 324028.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.652 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DLX3NM_005220.3 linkc.-64C>T 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 3 ENST00000434704.2 NP_005211.1 O60479
DLX3NM_005220.3 linkc.-64C>T 5_prime_UTR_variant Exon 1 of 3 ENST00000434704.2 NP_005211.1 O60479

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DLX3ENST00000434704.2 linkc.-64C>T 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 3 1 NM_005220.3 ENSP00000389870.2 O60479
DLX3ENST00000434704.2 linkc.-64C>T 5_prime_UTR_variant Exon 1 of 3 1 NM_005220.3 ENSP00000389870.2 O60479

Frequencies

GnomAD3 genomes
AF:
0.276
AC:
41906
AN:
152050
Hom.:
6486
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.315
Gnomad AMI
AF:
0.315
Gnomad AMR
AF:
0.229
Gnomad ASJ
AF:
0.292
Gnomad EAS
AF:
0.672
Gnomad SAS
AF:
0.386
Gnomad FIN
AF:
0.253
Gnomad MID
AF:
0.256
Gnomad NFE
AF:
0.227
Gnomad OTH
AF:
0.249
GnomAD4 exome
AF:
0.254
AC:
359783
AN:
1415884
Hom.:
51261
Cov.:
28
AF XY:
0.257
AC XY:
180814
AN XY:
703280
show subpopulations
African (AFR)
AF:
0.318
AC:
10400
AN:
32676
American (AMR)
AF:
0.249
AC:
9969
AN:
39978
Ashkenazi Jewish (ASJ)
AF:
0.280
AC:
7200
AN:
25684
East Asian (EAS)
AF:
0.697
AC:
26861
AN:
38534
South Asian (SAS)
AF:
0.386
AC:
32145
AN:
83246
European-Finnish (FIN)
AF:
0.254
AC:
10321
AN:
40562
Middle Eastern (MID)
AF:
0.282
AC:
1164
AN:
4122
European-Non Finnish (NFE)
AF:
0.225
AC:
245675
AN:
1091996
Other (OTH)
AF:
0.272
AC:
16048
AN:
59086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
14318
28637
42955
57274
71592
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8814
17628
26442
35256
44070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.276
AC:
41938
AN:
152168
Hom.:
6491
Cov.:
34
AF XY:
0.281
AC XY:
20890
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.315
AC:
13099
AN:
41522
American (AMR)
AF:
0.228
AC:
3495
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.292
AC:
1014
AN:
3472
East Asian (EAS)
AF:
0.671
AC:
3459
AN:
5154
South Asian (SAS)
AF:
0.385
AC:
1858
AN:
4826
European-Finnish (FIN)
AF:
0.253
AC:
2680
AN:
10590
Middle Eastern (MID)
AF:
0.255
AC:
75
AN:
294
European-Non Finnish (NFE)
AF:
0.227
AC:
15438
AN:
67986
Other (OTH)
AF:
0.252
AC:
533
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1570
3141
4711
6282
7852
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
436
872
1308
1744
2180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.246
Hom.:
17013
Bravo
AF:
0.277
Asia WGS
AF:
0.519
AC:
1805
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
0.74
DANN
Benign
0.69
PhyloP100
-1.7
PromoterAI
-0.063
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2278163; hg19: chr17-48072426; COSMIC: COSV71547551; COSMIC: COSV71547551; API